Altach is an NLC venture company. At Altach our goal is to become the gold standard in regenerative cartilage technology. We are building a portfolio of biomimetic cartilage grafts allowing surgeons to repair cartilage defects and restore patient’s quality of life. Altach is developing a portfolio of biomimetic cartilage scaffolds utilising Type II collagen which is the building block of native cartilage. The scaffolds are designed to be used stand alone and in conjunction with other cell based therapies. The implants unique composition create a matrix for the patient’s own cells to migrate into and regenerate the cartilage. Medical Devices, …

76 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

MEDICAL DEVICE ENGINEERING S.A.S to bring innovators the missing link in the development of their medical devices. We created MEDICAL DEVICE ENGINEERING S.A.S to bring innovators the missing link in the development of their medical devices and disposables.  The concept of your therapy, or surgery has been proven from the medical point of view (PoC) and you need a device?  Or you may simply have an idea and do not know where to start to make it concrete? Our Philosophy: A team composed of both Scientists & Engineers (plastics processing) to better understand each other, and to make …

209 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

Developing innovative implantable medical devices for orthopaedic applications Lamina Therapeutics is a pioneering biotechnology company, developing innovative medical devices promoting patient's active live. Lamina’s technology consists of a three-dimensional biodegradable wound dressing with nano-reservoirs including active therapeutics in combination with patient’s own stem cells. This unique multifunctional approach offers a variety of potential applications addressing unmet medical needs in the field of orthopaedics, maxillofacial and periodontal lesions. Lamina’s lead product lamina.ONE, offering a hybrid therapeutic action for the repair of cartilage as well as subchondral bone for a full recovery of the articular function, is expected to enter phase I/II …

82 similar entities Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology

Life after cancer exists, we are shaping it! Lattice Medical is a French medtech company pioneering regenerative medicine through tissue engineering and 3D printing technologies. We develop next-generation bioresorbable implants designed to support soft tissue regeneration and improve reconstructive surgery outcomes for patients after cancer and other major tissue loss. By combining biomaterials science, additive manufacturing and medical innovation, we create solutions that work with the body’s own healing mechanisms to enable more natural reconstruction approaches. Our technologies include: • MATTISSE a 3D-printed bioresorbable implant for breast reconstruction after mastectomy, designed to guide autologous tissue regeneration before gradually resorbing • …

75 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: 3D Printing Synthetic Biology

Manufacturer of a medical device for estimating the stability of orthopedic implants during placement ImpacTell is a high-potential company specializing in the medical device market in the field of orthopedic implant placement. Using know-how acquired over ten years of research, our team is currently developing a medical device capable of recovering information on the biomechanical properties of the bone-implant interface. By assisting surgeons in their decision-making, our solutions are designed to improve the success rate of total hip prostheses and patient care. Medical device, orthopedic implants, bone-implant interface, hip prosthesis, acoustics, and biomechanics

121 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Oxford, UK company exploiting the regenerative properties of silk for large gap peripheral nerve repair Newrotex is an Oxford-based SME that has developed the first implantable medical device capable of repairing 10cm peripheral nerve gaps, using the incredible properties of spider silk Peripheral Nerve Injury, Silk, Medical Device, Regenerative Medicine, and Biotech

101 similar entities Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology

BIOMOLECULES NOW, FOR YOUR FUTURE KYLYS is a Life Science Spin-off from the University of Geneva, now ready to step into clinical development. Passionate about science and biotechnology, we are committed to developing a unique technology to deliver highly effective and safe products based on the next generation of hyaluronic acid (HA). Our products are aesthetic (KYLYS Aesthetics) and medical (KYLYS). Our technology can revolutionize HA delivery for medical and surgical needs, in the field of: Aesthetic Rheumatology Reconstructive surgery Drug delivery system Veterinary

90 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Innovating BioMaterials & Medical 3D Printing TrabTech is a deep technology company that develops innovative medical products using innovative materials, new generation manufacturing technologies and biomimetic designs. TrabTech's personalized CMF Implants, tumor and revision prostheses are produced in accordance with ISO 13485 and IOS 9001 standards. The hip prosthesis produced by the additive manufacturing technique is one of the rare examples that was able to obtain CE Certificate in Class III class. Trabtech uses advanced materials such as PEEK, PEKK, Biopolymer and Bioceramic along with widely known materials such as Ti6Al4V, CoCr F75 in its implants. TrabTech who is a …

58 similar entities Type: Startup Activities: manufacturing deeptech healthtech Technologies: New Materials

"A new generation of biodegradable polymer-based medical devices" POLIMERBIO is a spin-off from the University of the Basque Country (UPV-EHU) that specializes in biodegradable materials for medical applications and tissue engineering. We focus on innovating and developing new biomedical products using bioabsorbable materials, aiming to replace non-biodegradable devices or create new application opportunities. Additionally, we offer customized design and development services for creating new synthetic routes. biopolimeros, Biomateriales, Productos Sanitarios, Materiales biodegradables, and Síntesis Química

92 similar entities Type: Startup Activities: deeptech Technologies: New Materials

Surgical Bone Substitute & Regeneration KERVALION develops 3D-printed bone grafts, custom-designed from patient scans. Initially intended for pre-implant dental surgery, these grafts are designed to treat bone deficiencies that prevent the placement of dental implants. Thanks to personalized manufacturing, they fit precisely in shape and volume, simplifying the procedure and reducing the number of surgical interventions required. KERVALION's innovative material ensures excellent biocompatibility while promoting reliable bone regeneration. This technology offers practitioners an easier, faster, and more cost-effective solution, making grafting accessible to a wider range of professionals while improving patient comfort. impression 3D, biomatériaux, and greffe osseuse

64 similar entities Type: Startup Activities: deeptech Technologies: New Materials

3D custom made implants AnatomikModeling creates 3D custom-made implants for Reconstructive&Aesthetic Surgery, Pneumology and Maxillofacial Surgery. Our 3D custom-made implants are designed for Pectus Excavatum, Poland Syndrome and others anatomy defects like hard or soft tissues loss. Medical Devices, Reconstructive surgery, Pectus Excavatum surgery, Poland Syndrome surgery, and 3D CAD CAM Medical implants

69 similar entities Type: Startup Activities: manufacturing healthtech Technologies: Synthetic Biology

Trusted CDMO for biomaterial based braided and coated medical device implants Galway Biomedical is a trusted CDMO for biomaterial based medical devices and implant products building a global reputation as a dependable and responsive ally to innovators commercializing cutting edge implantable medical devices. Contract Manufacturing , Medical Device Braiding , and Medical Device Coating

184 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Lack of cadavers and fresh tissue/organ models hinders the quality of medical education; therefore, there is a need for a reliable and sustainable training medium for ever-growing number of medical students and personnel. Surgitate designs and fabricates silicone-based surgical models that are engineered to simulate mechanical responses of real organs to incision, dissection, and suturing. In our product portfolio, we have skin, breast, and vascular models. Different suturing techniques, benign mass removal, and complicated oncoplastic surgery can be practiced on these models. We aim to improve the quality of surgical trainings via our practical, affordable, and tactile simulation platform. surgery, …

70 similar entities Type: SMB Activities: deeptech healthtech Technologies: New Materials

Bringing connectivity to biosensors. Digital biosensors for wearables, diagnostics and wound care. Grapheal is a spin-off from Neel Institute, at French Research Center CNRS in Grenoble. After 10 years of research and development on biomaterials fabrication and integration. Grapheal is born out of our will to improve chronic wounds medical care with a new generation of smart-bandages. The core of our technology is linked to graphene physical and biochemical properties. We use it as a bioactive material, an electrical plateform for wound stimulation, and a biodetection plateform to monitor healing in real time. Our smart-bandages benefits to both patients and …

67 similar entities Type: Startup Activities: healthtech deeptech Technologies: IoT Sensors

Facial & Body Remodeling Technology for Medical Aesthetics PB&B Ltd. is a specialty Swiss Life Sciences company founded by bioengineers working with plastic surgeons & dermatologists to test and bring to market a new patented injectable technology for the remodeling of soft tissues of the face & body. PBB-002 enhances adipocytes' volume with fatty acids, as to provide natural & longer-term results with the highest level of safety. PB&B’s patented technology aims to transform a fast growing, multi-billion-dollar facial aging & body remodeling markets with the next generation of injectables in Medical Aesthetics. Aesthetics, Facial rejuvenation, Breast augmentation, Buttock augmentation, …

69 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Gecko Biomedical is a fast-paced medical device company, dedicated to the development of innovative tissue reconstruction solutions. We are leveraging our technology platforms to develop novel solutions to disrupt the field of surgery and positively impact the life of patients.

153 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Our mission is to make new-generation advanced wound care products affordable and available for everybody At Biovotec we are working to shape the future of wound healing. By reducing the cost of advance wound care products, we offer an unrivaled advantage for both patients and clinicians. We believe that everybody should have access to affordable, advance wound care products. Generally the body has an amazing ability to heal itself. However, under some circumstances ulcers may form and wounds may heal slowly, becoming chronic. In these cases extensive treatment and medication are required and with a significantly increased healing time. In …

59 similar entities Type: Startup Activities: healthtech deeptech Technologies: Bio sourced materials

The new way of transplantation Stella Surgical is a European company based in the South of France. It was created to meet the needs of transplant surgeons, procurement and transplant teams, and organ transporters. Our promise: to increase the number of grafts available, and their safety during the entire transplantation process. Thus, we design, develop and market connected and innovative medical devices so that the coordination teams (harvesting and transplant) can plan transplants in the best possible conditions. Patients will therefore be able to benefit from better conditions during their transplant.

65 similar entities Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Custom-made external breast prosthesis. 3D medical device to identically replace the breast after breast cancer Custom-made external breast prosthesis. breast prosthesis, external prosthesis after breast cancer, 3D scanning, 3D printing, and CAD

65 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Personalized Transplants VERIGRAFT generates personalized tissue-engineered transplants for use in regenerative medicine. The company’s unique technology platform turns donated allogeneic (“foreign”) tissue into an autologous-like (“personalized”) tissue and thus avoids transplant rejection and the need for life-long immunosuppression. Donated, allogenic tissue is patient-individualized by a combination of DC (Decellularization) and RC (Reconditioning/Recellularization) processes. VERIGRAFT’s development pipeline comprises products in the areas of vascular regeneration as well as peripheral nerve repair.

65 similar entities Type: SMB Activities: biotech deeptech Technologies: SaaS

New solutions for autoimmune, inflammatory and bone diseases. BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of immunity, auto-immune diseases and organ repair. Cell therapy, Bone and joint tissue regeneration, Osteo-Articular Diseases, autoimmunity, immunity, autoimmune disease, and arsenic

106 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

L'os humain préservé et régénéré BIOBank is a leader providing high-quality bone allografts to surgeons in orthopaedics, maxillofacial, and dental surgery. Our bone grafts are sourced from living donors in France & processed via our perfected Supercrit® technology, providing key advantages to surgeons and patients: - Total viral-inactivation - Maintainance of biomechanical and structural intergrity of the tissue - Availability in various shapes & forms, allowing easy handling during the surgical procedure - High quality bone integration, improving patient recovery BIOBank assure l’ensemble des activités d’une banque de tissus, de la prise en charge des tissus (recueil) à la délivrance …

46 similar entities Type: SMB Activities: healthtech biotech

Bioglass Solutions for Bone Regeneration NORAKER, a French player in regenerative medicine,'s mission is to promote the reconstruction of the bones of patients who have undergone orthopedic or dental surgery. A spin-off from INSA Lyon in 2005, NORAKER innovates with its mastery of a biomaterial with exceptional properties: bioactive glass. NORAKER has been distributing its implants since 2015, with an international presence in more than 40 countries. The company invests in close and regular collaboration with surgeons and healthcare professionals, to always better meet the requirements of the medical environment. NORAKER products find their application in orthopedic, spine, CMF, ENT …

101 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Tetratherix has developed the first biostealth fluid matrix to disrupt regenerative medicine and targeted drug delivery. [ASX:TTX] Tetratherix has developed a proprietary fluid matrix that is invisible to the body & does not induce any foreign body reaction to evolve regenerative medicine and targeted therapeutic delivery. Tetramatrix is a water based polymer solution that forms an adhesive hydrogel once administered to the body. The product is fully synthetic, biocompatible and resorbable. After a decade of development with meticulous polymer programing, Tetratherix is advancing the world of biopolymers by developing real world applications specific to multiple indications in an effort to …

42 similar entities Type: Startup Activities: biotech Technologies: New Materials

Make tissues real Poietis (gr. Ποίησις: to make). "The one who makes things real."​ Poietis is a health-tech company specialized in the development of solutions for manufacturing human tissues by 4D Bioprinting. Poietis commercializes its Next Generation Bioprinting (NGB) systems for Cell Therapy & Research Centers and also develops advanced therapies with leading clinicians. 4D Bioprinting, Tissue engineering, Laser, bioprinting, skin, and cell therapy

61 similar entities Type: Startup Activities: deeptech manufacturing biotech Technologies: 3D Printing Synthetic Biology

Pioneering Solutions to Understand, Diagnose, and Treat Bone Conditions​ CompagOs is bringing better bone health to all by empowering researchers to transform discoveries into clinical applications, while enabling physicians to match patients with the right treatments and support faster recovery. At the core of our mission are our biologically relevant and reproducible Bon3OIDTM in vitro bone models, developed using state-of-the-art 3D bioprinting. Leveraging this technology, we are currently focused on developing a blood-based assay to detect bone metastases earlier than existing imaging methods, representing a key step toward advancing bone health. Additionally, we provide comprehensive services to academic researchers and …

70 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Reshaping rhBMP-2 Perspectives Relieving suffering and improving quality of life with next-generation orthobiologics. Regenerative Medicine, Biomaterials, Medical devices, Drug delivery, biotechnology, BMP2, Programmed Drug Release, and Instructive Tissue Scaffolds

230 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Our goal is to revolutionize bone regeneration for dental implants by developing superior bone graft substitute products with breakthrough technology and innovative procedure. The guiding light of the genesis of Wishbone is to design and fine-tune a high-tech recipe to extract and inactivate all proteins, including prions, from bovine bone, but which would preserve the highly osteoconductive micro and nano-topography of the natural bone. Wishbone biomaterials result from the collaboration between chemists, biomedical engineers and clinician experts in dental tissue engineering. Wishbone has invested in a high tech facility for R&D, production and QC, including a qualified ISO 7 cleanroom. …

70 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Belgium biotech company providing unique pipeline of medical devices in OsteoArthritis, skin aging and ophthalmology. Capitalizing on a history of innovation and expertise in exclusive natural chitosan chemistry, KiOmed Pharma, a spinout from KitoZyme, develops a unique pipeline of medical devices that address unmet medical needs in high impact pathologies and major social burdens such as invalidating OsteoArthritis, skin aging and ophthalmology. Medical Devices & Implants, Biomaterials, Rheumatology & Joint Health, Dermatology, Biosurgery, Regenerative Medicine, Ultrapure Chitosan, and Animal-free Chitosan

97 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Delivery of vision care EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with unmet medical needs such as glaucoma or dry eye. We develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts.

127 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Guiding the body to heal itself VIVOLTA is the healthcare industry’s trusted partner for contract development and manufacturing of electrospun medical products that guide the body to heal itself. Founded in 2008, we leverage our proud heritage as high-performance electrospinning equipment designer now as a leading CDMO for electrospun medical devices and drug delivery systems. Electrospinning, Nanotechnology, Biomaterials, MedTech, Medical Devices, Tissue Engineering Scaffolds, Medical Solutions, Polymers, Nanofibers, GMP, Scalable Manufacturing, Co-Development, Regenerative Medicine, Drug Delivery Solutions, Nanofibers, Tissue Engineering, Medical Electrospinning, Cardiovascular Devices, Sports Medicine Devices, General Surgery Soft Tissue Reconstruction, and MediSpin

108 similar entities Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Bringing precision to the power of biologics with pioneering use of synthetic nanoclays for regenerative medicine. Renovos Biologics Ltd. (Renovos) is a biotech/medtech company focussed on the development of its patented synthetic nanoclay, RENOVITE®, as a drug delivery platform for regenerative medicine and beyond. Regenerative Medicine, Biomaterials, Drug Delivery, Medical Devices, Pharmaceuticals, Stem Cells, Orthopaedics, and Biotechnology

109 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Soft Minimally Invasive Brain Computer Interfaces At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible.

65 similar entities Type: Startup Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Simpler joint replacement surgery. Biomimetic printing technology. OSSTEC is a medical technology company developing the next generation of cementless orthopaedic implants. Our lead product, ASCENT, is a cementless partial knee replacement designed to preserve healthy anatomy, restore natural movement and help patients remain active for longer. It combines advanced 3D-printed, bone-mimetic fixation with a simplified surgical workflow built for modern arthroplasty. Our technology is underpinned by more than a decade of research and developed through close collaboration between engineers, scientists and leading orthopaedic surgeons. We believe the future of partial knee replacement is cementless - and we are building the …

80 similar entities Type: Startup Activities: it services Technologies: Synthetic Biology

Materials engineered to advance research and development. BioSurfaces, based in Ashland, Massachusetts, is a life science company with deep leadership and a diverse team of specialists. The company’s proprietary electrospinning technology known as Bio-Spun® creates product solutions by engineering biology with synthetic cellular matrices for applications ranging from IVRT and delivery of bio-active therapeutics to medical devices and consumer health products. These materials can be made to form a variety of unusual and difficult-to-manufacture shapes while also demonstrating improved biocompatibility over other textile-based materials. The BioSurfaces manufacturing process also allows the incorporation of drugs or other bioactive agents directly into …

64 similar entities Type: SMB Activities: nanotech deeptech Technologies: Synthetic Biology

Your partner for preclinical research in Osteoarticular diseases, Inflammation, Skin diseases... Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») specialized in high-quality preclinical evaluation services in the field of inflammation, osteoarticular diseases and skin diseases. Thanks to its high expertise, Atlantic Bone Screen evaluates drug candidates, biomaterials (either for orthopedic or dental applications) and ingredients/products for cosmetics and food industry. We provide high-quality services to support the characterization of drug candidates, nutraceuticals, biomaterials,... Located in Nantes, North-West of France and created in 2005, Atlantic Bone Screen puts at your disposal a unique preclinical platform with a …

63 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid

202 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

The synthetic collagen revolution NVH Medicinal world expert in synthetic collagen NVH Medicinal is a biotechnology company based in Dijon, created at the end of 2008, whose mission is based on the treatment of pathologies linked to a collagen deficiency. It develops products derived from collagen, the most abundant protein in the body and whose dysfunctions cause numerous diseases (aging, cardiovascular, inflammatory, neurological diseases, fibrosis, cancer and rare diseases). NVH's ambition is to be recognized as an innovative player in the treatment of collagen-related diseases by becoming one of the world leaders in the development, production and marketing of a …

77 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

Developing revolutionary biomaterials for regenerative medicine. Spiderwort Inc. is a tissue engineering company specializing in the development of transformative biomaterials for repairing and regenerating tissues within the human body.

66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully …

151 similar entities Tags: FrenchTech120 Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Innovating Medical Devices Inomed Health Limited is a UK distributor of innovative medical implantable and disposable devices to the NHS and private healthcare institutions. We are a focused company supporting customers and manufacturers to constantly improve the way surgical and non-surgical treatments are performed, delivered through better medical technology to improve the lives of patients. Medical Devices, Interventional Radiology, Biopsy Devices, and Bariatric Health & General Surgery

411 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Aiming at perfect skin regeneration MORE than 100 million patients develop scars from elective surgeries each year in developed countries alone.Sunogel is primarily directed toward the development of novel and regenerative therapeutics. At Sunogel, we investigate, incorporate and innovate functional three-dimensional scaffolds that can unlock the power of regeneration for damaged tissues, especially skin regeneration.

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Dermo-innovation Feeligreen is a technology startup developing safe and effective micro-current devices for a wide range of cosmetic and therapeutic applications. With applications ranging from anti-ageing to wound healing, it develops and sells innovative drug-delivery systems to TIer1 pharmaceutical laboratories medical devices, therapeutics, cosmetics, and skincare

423 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

3D matrices for tissue reconstruction Application to breast reconstruction The MAT(T)ISSE project proposes to create a new bioprosthesis, a class 3 implantable medical device, which aims to help the body restore damaged regions following curative surgical interventions. This tissue restoration is carried out through the autologous collection of fat cells (adipose tissue) re-implanted on a synthetic and resorbable lace-type textile structure. The textile structure has a role of maintenance, assistance in the multiplication of implanted fat cells and revascularization. It is coupled with a bioresorbable and personalized 3D shell which delimits the volume to be reconstructed. Ultimately, the resorbable support …

56 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Donation and transplant: committed to improving the quality of life Fondazione Banca dei Tessuti del Veneto ETS is a healthcare facility that collects, conserves and distributes cardiac, vascular, osteotendinous, amniotic membrane, dermis and adipose tissue for transplantation, certifying their suitability and safety. The aim of the activity is to guarantee services that are increasingly compliant with the operational needs of surgeons, combining the high value of the donation with clinical applications, increasing the number of people who can benefit from a transplant of homologous tissue. In more than 20 years of experience, FBTV has refined its skills in the field …

38 similar entities Type: Startup Activities: healthtech

The platform for creating organs and tissues in the lab. The platform for creating organs and tissues in the lab. Biotechnology, Biomaterials, Bioprinting, 3D Cell Culture, Tissue Engineering, Hydrogels, Regenerative Medicine, Research, and Tissue Culture

128 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Pioneering Regenerative Medicine CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics. Our mission at CollPlant is to deliver ground-breaking …

62 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: 3D Printing Synthetic Biology

Biomimetic spider silk for 3D bioprinting and medical devices At PrintyMed, we are revolutionizing the future of medicine and materials through the innovative power of biomimetic spider silk. Our mission is not just about creating materials — it’s about redefining possibilities. Whether it’s replacing invasive procedures with advanced prostheses, accelerating research with organ-on-a-chip membranes, or crafting sustainable beauty products, PrintyMed is driven by the desire to improve lives.

75 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Silk innovation for life sciences KLISBio is a clinical-stage regenerative medicine company. We are developing several innovative technology platforms based entirely on natural silk fibroin, which allow for the creation of various solutions for endogenous tissue repair and regeneration. Silk is one of the most renowned and ancient materials used in medicine. In its raw state, silk consists of two main proteins, sericin and fibroin, with a glue-like layer of sericin coating two singular filaments of fibroin. Silk fibroin is fully biocompatible and promotes cell proliferation by also stimulating in-vivo tissue regeneration. Depending on the technology used, it provides a …

64 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

From replacement to regeneration osteobionix is a company dedicated to advancing the standards of care for people suffering from cartilage or bone loss. Cartilage and bone loss may result from a variety of causes including osteoarthritis, trauma and tumor and can severely affect a person’s lifestyle. osteobionix wants to provide people suffering from cartilage or bone loss with innovative, high quality, proven, customized solutions, which can help them regain the lifestyle they deserve. osteobionix collaborates with surgeons in designing and manufacturing reliable, cost-effective solutions, which take into account the uniqueness and complexity of each single surgical case. osteobionix strives to …

58 similar entities Type: SMB Activities: deeptech manufacturing Technologies: 3D Printing Synthetic Biology

Tissue fingerprinting as an innovation to better diagnose and treat brain diseases Medimprint develops innovative, non-lesion medical devices, for clinical research in brain tumors and neurodegenerative diseases. Based on a new concept, “the brain tissue imprint”, Medimprint’s products are the new generation of companion medical devices for personalized and targeted therapies. The non-lesion feature of this concept allows an exclusive in vivo access to : - Tumor heterogeneity - Peritumoral regions - Neurodegenerative regions for poly-omic molecular analyses. Medimprint’s technology breakthrough relies on the integration of functionalized silicon chips to surgical stylet for atraumatic sampling. Through an original « hide …

62 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Restore your body through the power of self-regeneration Founded in 2020, Healshape is a French global regenerative medicine company, with a clear mission: “Enabling people to restore their physical integrity through self-regeneration”. We are committed to transforming the way soft tissue reconstruction is approached, moving away from synthetic implants and toward biological harmony. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, Tissue engineered products, Lyon, France, self-regeneration, and Start-up

86 similar entities Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology

🔬 French manufacturer of medical devices based on biopolymer (P4HB) Apha Biomat is part of the Ph Tech group, together with Meccellis Biotech (expert in biologics for Soft Tissue repair). Apha Biomat’s new industrial facility will support Xenopha’s manufacturing operations, alongside with Meccellis. Xenopha is the result of an intensive R&D program aiming at combining Meccellis’ expertise in biologics with a new biopolymer:P4HB. This hybrid combination allows for the design of natural 3D medical devices. Xenopha’s first indication is dedicated to breast reconstruction where a solution to replace silicon is eagerly awaited by patients and surgeons. For any further information, …

119 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Making tissue therapeutics possible to defeat serious disease Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte platform, based on twenty years of disruptive and patent-protected R&D, we are creating new ways to target serious diseases using precision-engineered biological tissues. Our transplantable tissues have the potential to help patients living with uncurable tissue damage related to cardiac, pulmonary, metabolic, kidney and other diseases. Fluicell’s first ambitious goal is to develop transplantable tissues to cure type 1 diabetes, impacting the lives of millions of patients. Nexocyte-generated tissues also enable …

98 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Shaping the future of regenerative medicine At 4Tissue, we’re pioneering the future of regenerative medicine with innovative hydrogel solutions that support natural tissue restoration. We are an innovation-led research and clinical development organization. Our mission is to redefine the boundaries of tissue reconstruction, regeneration, and anti-aging, utilizing innovative biocompatible and bioresorbable polymers platform The first product, a bioresorbable injectable hydrogel, is focused on a better cell survival and the full regeneration of adipose tissue for breast reconstruction and augmentation applications.

118 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS

We design and supply artificial tissue environments for cell culture & bioprinting applications. Biogelx is helping people work in translational science, drug discovery and tissue engineering by 'making in vitro cell cultures more in vivo'​. We do this through manufacturing and supplying 3D cell cultures that can be tuned to specific tissues and synthetic bio-inks that are reproducible, scalable, easy to handle and suitable for clinical decision making. Our portfolio of biomaterials is comprised of synthetic peptide hydrogels that act as extracellular-matrix environments to support cell growth. In addition, the chemical and physical properties of our biomaterials can be precisely …

87 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Starting in the mid 1990’s, the founders of Nanovation Partners LLC sponsored research at the University of California at San Diego (UCSD) in the lab of Sungho Jin, PhD. This research showed enhanced osseointegration and reduced implant surface infection by forming thousands of rows of tiny metal oxide nanotubes per square millimeter on the medical implant-to-tissue surface. These nanotubes were formed into the metal oxide surface already present on metal implants. No new materials were formed and no synthetic hydroxyapatite or other coating was needed. The group noticed that nearby stem cells treated the nanotube surfaces more like the outer …

59 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: New Materials Synthetic Biology

Innovative Biosurgery Founded in 2005 and based in the Lyon suburb of Saint-Priest (France), Biom’up develops and commercializes hemostatic products based on patented biopolymers designed to simplify traditional and laparoscopic surgical procedures in numerous specialties such as cardiac, general and orthopedic, and give patients a better quality of life. The Company’s lead product, HEMOBLASTTM Bellows, is marketed in Europe and the United States. Biotechnologie, Dispositifs Médicaux Implantables, Collagène, Equipements médicaux, Hémostase, Innovative biosurgery, Medical devices, Hemostasis, Collagen, Biotechnology, Pharmacy, Hemoblast, hemostatic, medical devices, and hemostasis

220 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

experts in bone regeneration Biomatlante is a specialist in synthetic biomaterials promoting bone regrowth and the precursor of bone substitute technologies. We market our products for orthopedic, trauma, spine, ENT, stomatological and dental surgery in more than 50 countries. Our Mission Develop and promote the proprietary MBCP® Technology as the scaffold of reference in any bone regeneration solution for best-in-class patient care. Our Vision Bone surgeries often demand grafts for which autograft is considered as the gold standard in terms of tissue regeneration performance and limited rejection risk. Autograft is available in limited quantity though, and harvesting methods are expensive …

73 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Next Generation Biofabrication - Sound Induced Morphogenesis //Acoustic biofabrication MimiX biotherapeutics introduces Sound Induced Morphogenesis. We extend the boundaries of biofabrication, making bioengineered, artificial human organs and tissues a future reality. Sound Induced Morphogenesis (SIM) is a revolutionary approach in biofabrication. It mirrors nature’s design, to aggregate and pattern biologicals by tuning sound profiles under contactless, fast and delicate culture conditions resulting in a morphologically induced tissue generation. We introduce cymatiX®, a unique acoustic biofabrication solution that makes the Sound Induced Morphogenesis technology easily accessible to the scientific and clinical community Visit www.mimixbio.com to learn more. mimiX biotherapeutics is a …

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transforming Bone Repair The standard of care for healing broken bones hasn't changed in over fifty years. Invasive metal hardware is still routinely used to fixate bones–often with less-than-optimal patient outcomes. RevBio® is a medical device company that has invented TETRANITE®, a regenerative bone adhesive currently in 150 patients across seven FDA approved clinical trials. Our patented “bone glue” is founded upon a comprehensive patent portfolio with global patent protection extending through 2042. Easily injectable into a range of musculoskeletal defects, TETRANITE has demonstrated superior performance over other standard of care options in curing speed and strength, rate of resorption, …

57 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Collagen products for the research, cosmetics & medical sectors We are a highly innovative biotech company developing collagen-based biomaterials to address emergent needs in the research and medical fields. We focus specifically in the development, manufacturing and supply of highly purified research and medical grade collagen. Our collagen products are extracted using proprietary methods under carefully controlled conditions in order to fit specific customer requirements for a wide range of research, clinical and cosmetic/skincare applications. High quality collagen, Biomaterials , and Medical grade collagen

61 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori). Recent advances in our understanding of fibroin biochemistry has allowed expansion of the versatility of the material into alternate physical formats such as hydrogels and implants loaded with active drug substances. Cocoon is leveraging silk fibroin as a novel biomaterial for the stability and delivery of therapeutics across human health and animal health. Cocoon’s first products are …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We developed a new generation of cell therapy products to regenerate articular cartilage damage: Cartibeads Vanarix has developed a new generation of cell therapy to produce high-quality hyaline cartilage mini-grafts, named Cartibeads, which resemble native tissue. Cartibeads are bio-engineered cartilage implant made from allogeneic chondrocytes. When implanted during minimally invasive arthroscopic surgery, Cartibeads can completely self-integrate into cartilage lesions and thus regenerate the tissue. Cartibeads are designed for the treatment of cartilage defects in traumatic and osteoarthritic joints. #cartilagerepair #cartilageregeneration #celltherapy #kneerepair #osteoarthritis

59 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Surgical tissue repair At Regenosca, we’re pioneering the future of regenerative medicine with a breakthrough platform that enables the body to heal itself—without synthetic implants or tissue grafts. Our 100% engineered, natural collagen scaffolds guide perfect tissue regeneration, offering a safer and more effective alternative to traditional treatments. With 100% success in urethra reconstruction—our initial indication in urology—demonstrated in a first-in-human trial (sustained at two-year follow-up), we’re proving the potential of our technology to transform tissue restoration across multiple medical fields. Our goal? To make tissue regeneration a reality for patients worldwide, through collaborations with clinicians, researchers, and industry partners. …

70 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Addressing the problem of natural repair of soft tissues with injectable 3D scaffolds Volumina Medical is a multi-award-winning start-up active in the field of medical devices supported by a solid network of investors. The company develops breakthrough innovations for plastic and reconstructive surgery. The first product is an implantable polymeric biomaterial and targets the regeneration of soft tissue of the human body which are damaged after tumor excision, genetic malformation or trauma. Implants, Biomaterial, and Regenerative Medicine

132 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Implant Coating Experts MedicalGroup is a contract manufacturing partner for orthopaedic, spinal and dental implant companies around the world, since 1989, Our activities, all ISO 13485 certified, offer global solutions : Powder : manufacturing of Hydroxyapatite powder for plasma spray, biologics, lab analysis, 3D Printing Coating: metallic (Ti and CrCo) and ceramic (HA and alumina) coatings of medical devices (MasterFile for US market) Packaging: cleaning and packaging of medical and surgical devices Lab: microbiological and physico-chemical analysis. Biomaterials and bone substitutes for orthopaedic and dental applications Revêtements métallique et ceéramique sur dispositifs médicaux implantables, Poudre d'Hydroxyapatite, sous-traitant orthopédique, and Nettoyage …

70 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

OssDsign is a developer and global provider of next-generation bone graft-substitute products. OssDsign is a developer and global provider of next generation orthobiologics products. Based on cutting edge material science, the company develops and markets products that support the body's own healing capabilities, giving patients back the life they deserve. Website: www.ossdsign.com Newsroom: https://news.cision.com/ossdsign-ab (Always consult Instructions for Use which accompany the products for complete indications, contraindications, warnings and precautions.) Medical devices, Bone regeneration, Bonegraft, Orthopaedic surgery, Spine surgery, and Orthobiologics

190 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Preparation Manipulation Imaging LLS ROWIAK Laser LabSolutions GmbH develops and provides advanced laser-based systems and services for cutting, imaging, tissue and material processing, and cell manipulation. Our technologies support applications in pharmaceutical and biotechnological research, medical device and implant development, as well as material sciences for testing and quality analysis. Laser Microtome – Innovative Sample Preparation For histopathological studies or in vitro tests involving calcified or mineralized tissue or implanted materials (e.g., bone, dental tissue, cochlea, vascular stents, ceramics, or dental screws), our laser microtome offers an innovative solution for fast and precise sample preparation. Instead of a knife of …

69 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology New Materials

We turn medical devices into clinical reality neo-bionica bridges the gap between research and the clinic, providing world-class engineering expertise and links to leading clinicians to create life changing medical device solutions. Offering end-to-end medical device prototype development, from initial concept and rapid prototyping to pre-clinical testing and first-in-human prototypes for clinical trials

180 similar entities Type: Startup Activities: deeptech healthtech biotech manufacturing Technologies: Synthetic Biology

CrannMed is developing resorbable embolization technologies CrannMed is a medical technology company developing resorbable embolisation therapies for chronic musculoskeletal conditions. Founded in 2018, CrannMed brings together world-leading expertise across clinical, material science and medical technology to advance next-generation resorbable microspheres designed to deliver therapeutic effect safely. While permanent microspheres have been used for decades in oncology and other embolisation procedures, resorbable embolisation opens new possibilities in musculoskeletal medicine including Knee Osteoarthritis, Adhesive Capsulitis (Frozen Shoulder) and Plantar Fasciitis - conditions affecting millions of patients worldwide. Commercialisation, medical devices, medical device companies, Embolization, Microcatheters, and Peripheral

85 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Innovation to enhance bone healing. Our mission is to advance the science of bone regeneration through cutting-edge research and continuous innovation by partnering with researchers and physicians. We provide patients with safe, effective products that treat bone defects and promote healing. Bone regeneration, Orthopaedics, Traumatology, Bone substitute, Innovation, Bone void, Biomimetic and Bioactive bone substitute , and Medical Device

82 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Advanced Biomaterials for Regenerative Medicine Tensive is a biomedical company developing advanced biomaterials for regenerative medicine applications, with a current focus on reconstructive surgery after breast cancer.

77 similar entities Type: Startup Activities: deeptech healthtech Technologies: New Materials Synthetic Biology

Tiss’You – Regenerative Company – researches and develops medical devices to upgrade your body’s natural healing ability Tiss'You - Regenerative Company - researches and develops medical devices for regenerative medicine to help doctors and patients with innovative therapeutical solutions. Tiss'You is also a production facility of 850 sqm of which 240 sqm are clean rooms. We have next-generation equipments for R&D, production and quality control; 2 patents, 4 tissue substitutes and 2 point-of-care cell therapy devices. medicina rigenerativa, ricerca e sviluppo, clinica privata, prevenzione, innovazione, ortopedia, chirurgia vascolare, wound healing, lipocell, monocytes, integratori alimentari, regenerative medicine, food supplements, biomaterials, medical …

128 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

A bone-like, highly osteoconductive, patient-specific bioceramic implant At Cerhum, we enhance maxillofacial surgery with osteoconductive, patient-specific 3D-printed bioceramic implants. By combining advanced bioceramic materials with our patented porous structure, we promote rapid vascularization and osteointegration for reliable bone regeneration. These solutions combine biological properties with the advantages of patient-specific implants (PSI), powered by our patented porous structure. The result? Faster surgeries, fewer complications, and superior aesthetic outcomes. By eliminating donor-site risks and reducing surgical complexity, we help surgeons operate efficiently while achieving predictable, long-term results and improving patient recovery. Our mission is to enhance maxillofacial surgery through innovative and practical …

68 similar entities Type: Startup Activities: manufacturing deeptech industry 4.0 healthtech Technologies: 3D Printing Synthetic Biology

A Revolutionary Platform for Regenerative Medicine Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research. At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications. Medical Grade Collagen, Native Collagen, Cell Culture Reagents, Wound Healing, Hydrogels, Non Mammalian Collagen, Collagen, Reagents, Marine Biotechnology, regenerative medicine, 3dscaffolds, collagencoatedplates, and 3dsponges

75 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Customized Bioprinting systems and Bioreactors. Creating Life Changing Futures. REGEMAT3D develops customized Bioprinting Systems and Bioreactors - BMAP. We create Living Tissue Technologies. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, to improve people ́s quality of life. bioprinting, regenerative medicine, biotechnology, and tissue engineering

71 similar entities Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

Powering the future of medicine® We support the advancement of cell and gene therapies through our portfolio of cytokines and media supplements, along with a comprehensive suite of manufacturing services—including the production of proteins, media and buffers, and transfection and transduction reagents. We ensure your raw materials are as innovative as your therapies. GMP cytokines, Crypreservation media, Hemaotopietic and Mesechymal Cells and sources, Sterile Fill & Finish, Media & Buffers, Transfection Reagents, Human Plasma Derived Products, and Growth Factors

181 similar entities Type: SMB Activities: deeptech manufacturing biotech Technologies: Synthetic Biology

We engineer, manufacture and market world leading products for use in infection management in bone and soft tissue. Biocomposites is an international medical devices company that engineers, manufactures, and markets world leading products for use in infection management in bone and soft tissue. Based in Keele, UK, it has global operations across Europe, USA, Argentina, Brazil, Canada, China, India and Australia. Biocomposites is a world leader in the development of innovative calcium compounds and bone cements for surgical use. Its products regenerate bone and target infection risks across a variety of specialties, including musculoskeletal infection, orthopaedics, trauma, spine, foot and …

61 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Healing Beyond Absorption Bioretec is a global leader in fully absorbable orthopedic implants that promote healing with over two decades of clinical experience and continuous innovation resulting in breakthrough designation. Bioretec's implants are not only designed to fixate bone but rather restore mobility and support bone healing, eliminating the need for implant removal surgery and reducing complication rates. Bioretec’s implants leave nothing behind —only healing beyond absorption. biomaterials, medical, manufacturing, medical devices, implants, absorbable metal, biopolymers, orthopaedics, pediatric surgery, foot and ankle, trauma, and foot surgery

67 similar entities Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Helping people heal with 3D printed medical devices made from 4Degra®. Regenerative, resorbable and customisable. Parent company of the 4D Group, 4D Medicine Ltd is dedicated to shaping the future of implantable medical devices made from proprietary resorbable biomaterials. The 4D Group’s technology platform is centred around 4Degra®, a patent protected resorbable photocurable resin based on unique polycarbonate urethane chemistry. A result of 15 years rigorous academic research in leading U.K. universities, 4Degra® promises to free resorbable medical device design from historic constraints and overcome the clinical performance issues of current material options. The first medical devices to be made …

60 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: 3D Printing Synthetic Biology